Nanjing Zenshine Pharmaceuticals Co., Ltd. announced that it has received CNY 100 million in funding from Hubei Jumpcan Pharmaceutical Co., Ltd., Kunlun Capital, Zhejiang Saizhi Bole Equity Investment Management Co., Ltd, Zhongshan Zhonghui Investment Group Co.,ltd.
October 12, 2023
Share
On October 13, 2023, Nanjing Zenshine Pharmaceuticals Co., Ltd. closed the transaction. The company has raised over CNY 100 million in the transaction. The transaction included participation from Hubei Jumpcan Pharmaceutical Co., Ltd. for 3.40520% stake for CNY 60 million, Kunlun Capital, Zhejiang Saizhi Bole Equity Investment Management Co., Ltd, Zhongshan Zhonghui Investment Group Co.,ltd.
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD., formerly Hubei Hongcheng General Machinery Co., Ltd., is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products include heat-clearing and detoxifying series, digestive system series, pediatric series, breathing series, cardiovascular series and gynecology series. Its pharmaceuticals consist of tablets, mixtures, injections, capsules, granules and sprays, among others. The Company mainly distributes its products within domestic markets.
Nanjing Zenshine Pharmaceuticals Co., Ltd. announced that it has received CNY 100 million in funding from Hubei Jumpcan Pharmaceutical Co., Ltd., Kunlun Capital, Zhejiang Saizhi Bole Equity Investment Management Co., Ltd, Zhongshan Zhonghui Investment Group Co.,ltd.